Diagnostic performance of [18F]fluorodeoxyglucose positron emission tomography– computed tomography in cyst infection in patients with autosomal dominant.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Positron emission tomography in the diagnosis of cyst infections
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Diagnostic Management of Suspected Acute Cyst Complication
Rapid streptococcal testing for sore throat and antibiotic resistance
Volume 59, Issue 2, Pages (February 2011)
I.J. Schalk  Clinical Microbiology and Infection 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
An update on bacterial brain abscess in immunocompetent patients
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Whole genome sequencing of clinical isolates of Giardia lamblia
Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections  A. Hot, C. Maunoury, S. Poiree, F.
Virological tools to diagnose and monitor hepatitis C virus infection
The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis  K. Orvin, E. Goldberg, H. Bernstine, D. Groshar,
Refugee crisis and re-emergence of forgotten infections in Europe
Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease 
R. Cantón  Clinical Microbiology and Infection 
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
Rapid streptococcal testing for sore throat and antibiotic resistance
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Infected kidney cysts Kidney International
Pyogenic hepatic abscess: clues for diagnosis in the emergency room
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Interest of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of relapse in patients with spinal infection: a.
A. Skiada, L. Vrana, H. Polychronopoulou, P. Prodromou, A. Chantzis, P
Vector control: a cornerstone in the malaria elimination campaign
Do we need new antibiotics?
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis  J. Jung, M.Y. Kim, H.J. Lee, Y.S. Park, S.-O.
G. Höffken  Clinical Microbiology and Infection 
Isospora belli Clinical Microbiology and Infection
CMI editorial report 2011 Clinical Microbiology and Infection
C. P. Bleeker-Rovers, A. Warris, J. P. H. Drenth, F. H. M. Corstens, W
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose 
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T
Metagenomics and probiotics
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Clinical microbiological case: refractory chest wall infection following reconstructive surgery in a patient with relapsed lung cancer  A. Safdar, M.
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study  J.M. Costerus, M.C. Brouwer,
Current experience in treating invasive zygomycosis with posaconazole
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Molecular identification of Acinetobacter sp
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Statin use and clinical outcomes among pneumonia patients
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
Kar Neng Lai, Andrew S H Lai, Desmond Y H Yap, Matthew M T Ng 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections.
Presentation transcript:

Diagnostic performance of [18F]fluorodeoxyglucose positron emission tomography– computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease  M. Bobot, C. Ghez, B. Gondouin, M. Sallée, P.E. Fournier, S. Burtey, T. Legris, B. Dussol, Y. Berland, P. Souteyrand, L. Tessonnier, S. Cammilleri, N. Jourde-Chiche  Clinical Microbiology and Infection  Volume 22, Issue 1, Pages 71-77 (January 2016) DOI: 10.1016/j.cmi.2015.09.024 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Episodes of suspicion of cyst infection among autosomal dominant polycystic kidney disease patients. Black symbols: cyst infection. White symbols: no cyst infection. Clinical Microbiology and Infection 2016 22, 71-77DOI: (10.1016/j.cmi.2015.09.024) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Comparison of imaging techniques in a patient with autosomal dominant polycystic kidney disease and hepatic cyst infection. (a) Low-dose tracking computed tomography (CT) image showing polycystic liver with no spontaneous cyst hyperdensity. (b) [18F]fluorodeoxyglucose (18-FDG) positron emission tomography (PET) image showing hypermetabolism of the hepatic cyst wall. (c) 18-FDG PET–CT fusion image showing hypermetabolism of the cyst wall and allowing precise localization of the infected cyst. (d) CT image with injection of iodinated contrast agent, showing no thickening or enhancement of the cyst wall. (e) T1 magnetic resonance imaging sequence, showing the liquid level within the cyst but no wall thickening. (f) Hepatic cyst puncture with CT, guided by the results of 18-FDG PET–CT, showing positive culture (Escherichia coli). Clinical Microbiology and Infection 2016 22, 71-77DOI: (10.1016/j.cmi.2015.09.024) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 [18F]Fluorodeoxyglucose (18-FDG) positron emission tomography–computed tomography (PET–CT) sequence in a patient with hepatic and renal cysts. (a–c) 18-FDG PET–CT image showing pathological hypermetabolism of the left renal cysts (arrowhead) and a hepatic cyst (arrow). (d–f) 18-FDG PET–CT scan performed after 8 weeks of antibiotic treatment (persistence of elevated C-reactive protein level), showing the disappearance of kidney hypermetabolic foci (arrowhead), but the persistence of a hypermetabolic hepatic cyst, which led to the continuation of antibiotics for an additional 2 weeks with complete resolution of blood inflammation. Clinical Microbiology and Infection 2016 22, 71-77DOI: (10.1016/j.cmi.2015.09.024) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions